Advertisement
Advertisement
AZN
AstraZeneca PLC
184.64
USDSponsored
+0.72
+0.39%
May 19, 15:59 UTC -4
Closed
After-Market
185.00
+0.36
+0.19%
AZN Earnings Reports
Positive Surprise Ratio
AZN beat 25 of 41 last estimates.
61%
Next Report
Date of Next Report
Jul 27, 2026
Estimate for Q2 26 (Revenue/ EPS)
$15.91B
/$2.57
Implied change from Q1 26 (Revenue/ EPS)
+4.08%
/-0.39%
Implied change from Q2 25 (Revenue/ EPS)
+10.07%
/+18.43%
AstraZeneca PLC earnings per share and revenue
On Apr 29, 2026, AZN reported earnings of 2.58 USD per share (EPS) for Q1 26, missing the estimate of 2.59 USD, resulting in a -0.47% surprise. Revenue reached 15.29 billion, compared to an expected 15.40 billion, with a -0.75% difference. The market reacted with a -0.79% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analysts forecast an EPS of 2.57 USD, with revenue projected to reach 15.91 billion USD, implying an decrease of -0.39% EPS, and increase of 4.08% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Compugen Ltd
Report Date
May 18, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.08
Surprise
-8.11%
Satellos Bioscience Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.61
Actual
-$0.53
Surprise
+13.58%
Rani Therapeutics Holdings, Inc. Class A Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.04
Surprise
+12.85%
aTyr Pharma, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.14
Actual
-$0.11
Surprise
+21.60%
Citius Oncology, Inc. Common Stock
Report Date
May 15, 2026 For Q2 26
Estimate
-$0.01
Actual
-$1.43
Surprise
-13919.61%
Instil Bio, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.59
Actual
-$0.62
Surprise
-4.04%
Annovis Bio, Inc.
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.40
Actual
-$0.63
Surprise
-56.37%
CervoMed Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.79
Actual
-$0.86
Surprise
-8.09%
Lantern Pharma Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.36
Actual
-$0.30
Surprise
+18.30%
Cocrystal Pharma, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.17
Surprise
-11.11%
FAQ
What were AstraZeneca PLC's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, AstraZeneca PLC reported EPS of $2.58, missing estimates by -0.47%, and revenue of $15.29B, -0.75% below expectations.
How did the market react to AstraZeneca PLC's Q1 2026 earnings?
The stock price moved down -0.79%, changed from $186.68 before the earnings release to $185.20 the day after.
When is AstraZeneca PLC expected to report next?
The next earning report is scheduled for Jul 27, 2026.
What are the forecasts for AstraZeneca PLC's next earnings report?
Based on 6
analysts, AstraZeneca PLC is expected to report EPS of $2.57 and revenue of $15.91B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement